July 9, 2013
A programming error was reported by the company's data management vendor.
February 14, 2013
Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The open-label, ...
February 7, 2013
Medivation, Inc. (MDVN) recently announced that its partner Astellas Pharma Inc. (ALPMY) reported Xtandi (enzalutamide) sales ...
January 10, 2013
Geron Corporation (GERN) announced that it has signed an Asset Contribution Agreement with BioTime, Inc. (BTX) and BioTime's ...